Imiquimod - Melanoma

You are here : Home > Formulary Search > Imiquimod - Melanoma

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Red

Formulations :

Not Specified

Formulary Status :

Primary Care

ASPH

RSFT

SASH

SABP

Associated Icons :

BNF SPC

Restrictions / Comments :

Important

Indication: in transit metastases from melanoma

Documentation

No records returned.

PAD Profile

ChemicalSubstance :

Imiquimod

Indication :

Melanoma

Group Name :

Keywords :

in transit metastases from melanoma

Brand Names Include :

Important Information :

Latest Additions Date From :

Latest Additions Date To :

Guidelines :

Supporting Documents :

Other Indications

Below are listed other indications that Imiquimod is used to treat.

No records returned.

Other Drugs

Below are listed other drugs that are used to treat Melanoma.

No records returned.

Committee Recommendations (1)

05 Feb 25 - Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

This drug has been included on the joint formulary having been agreed by the DTC of at least one Surrey Heartlands Acute Trust.

See “Formulary Status” to identify where this drug has been agreed for use.